T regulatory cell function in idiopathic minimal lesion nephrotic syndrome

被引:110
作者
Araya, Carlos [2 ]
Diaz, Leila [2 ]
Wasserfall, Clive [3 ]
Atkinson, Mark [3 ]
Mu, Wei [4 ]
Johnson, Richard [4 ]
Garin, Eduardo [1 ,2 ]
机构
[1] Div Pediat Nephrol, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pediat, Gainesville, FL USA
[3] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA
[4] Univ Florida, Dept Med, Gainesville, FL USA
关键词
Minimal lesion nephrotic syndrome; T regulatory cell; Cytokines; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; LYMPHOCYTE POPULATIONS; LIPOID NEPHROSIS; IN-VITRO; EXPRESSION; INTERLEUKIN-2; CHILDREN; RECEPTOR; ACTIVATION;
D O I
10.1007/s00467-009-1214-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The purpose of this study was to test the hypothesis that, in idiopathic minimal lesion nephrotic syndrome (IMLNS), the T regulatory (T reg) cell suppressor mechanism is deficient, thereby enhancing cytokine release by T effector cells. Twenty-one patients with IMLNS, eight healthy controls and two patients with nephrotic syndrome and membranoproliferative glomerulonephritis were studied. The percentage of T reg cells was similar in the healthy controls and in patients with IMLNS in relapse or in remission. Thymidine incorporation in autologous T effector cells, as well as expression of the regulatory cytokine interleukin (IL)-10, was significantly reduced in patients in relapse when compared with patients in remission and healthy subjects. IL-2 expression was also reduced in patients in relapse but did not achieve statistical significance. In a different set of experiments, T cells, from subjects with IMLNS in remission, when stimulated with antiCD3-antiCD28 antibodies, secreted increased levels of cytokines. No such increase in cytokines was observed when cells from healthy controls were stimulated with same mitogen. The impaired T reg cell function observed in these patients may have pathogenic and therapeutic implications, because it could explain the persistence of the proposed pathogenic cytokines observed in the patients with IMLNS.
引用
收藏
页码:1691 / 1698
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 1978, KIDNEY INT, V13, P159
[2]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[3]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[4]   No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes [J].
Brusko, Todd ;
Wasserfall, Clive ;
McGrail, Kieran ;
Schatz, Richard ;
Viener, Hina Lee ;
Schatz, Desmond ;
Haller, Michael ;
Rockell, Jennifer ;
Gottlieb, Peter ;
Clare-Salzler, Michael ;
Atkinson, Mark .
DIABETES, 2007, 56 (03) :604-612
[5]   INCREASE OF TUMOR-NECROSIS-FACTOR-ALPHA SYNTHESIS AND GENE-EXPRESSION IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME [J].
BUSTOS, C ;
GONZALEZ, E ;
MULEY, R ;
ALONSO, JL ;
EGIDO, J .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (12) :799-805
[6]   Up-regulation of interleukin-4 and CD23/FcεRII in minimal change nephrotic syndrome [J].
Cho, BS ;
Yoon, SR ;
Jang, JY ;
Pyun, KH ;
Lee, CE .
PEDIATRIC NEPHROLOGY, 1999, 13 (03) :199-204
[7]  
CHURG J, 1970, LANCET, V1, P1299
[8]  
Daniel V, 1997, CLIN NEPHROL, V47, P289
[9]   When ligand becomes receptor -: tolerance via B7 signaling on DCs [J].
Finger, EB ;
Bluestone, JA .
NATURE IMMUNOLOGY, 2002, 3 (11) :1056-1057
[10]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992